Computational opioid prescribing: A novel application of clinical pharmacokinetics

Journal of Pain and Palliative Care Pharmacotherapy

Volumn 25, Issue 2, 2011, Pages 125-135

  Linares, Oscar A ^a,b   Linares, Annemarie L ^b,c  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b Monroe Pain Center   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

Author keywords

clinical pharmacokinetics; dose optimization; dose regimen design; dosing; opioids; pharmacokinetics

Indexed keywords

BUPRENORPHINE; CODEINE; FENTANYL; HYDROCODONE; HYDROMORPHONE; METHADONE; MORPHINE; MORPHINE SULFATE; OPIATE; OXYCODONE; OXYMORPHONE; PETHIDINE; TRAMADOL;

ADULT; ANALGESIA; ARTICLE; BACKACHE; BOOTSTRAPPING; CLINICAL ARTICLE; COMPUTATIONAL OPIOID PRESCRIBING; CONTINUOUS INFUSION; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG DOSE REGIMEN; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INFUSION; DRUG OVERDOSE; FEMALE; HOSPITAL INFORMATION SYSTEM; HUMAN; LOADING DRUG DOSE; MALE; MATHEMATICAL MODEL; MAXIMUM PLASMA CONCENTRATION; PAIN; PHARMACOLOGICAL PARAMETERS; PRESCRIPTION; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADULT; ANALGESICS, OPIOID; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PAIN; PHYSICIAN'S PRACTICE PATTERNS; POINT-OF-CARE SYSTEMS;

EID: 79958291454     PISSN: 15360288     EISSN: 15360539     Source Type: Journal    
DOI: 10.3109/15360288.2011.573527     Document Type: Article

References (51)

1. Bonham V. Race, ethnicity, and pain treatment: striving to understand the causes and solutions to the disparities in pain treatment. J Law Med Ethics. 2001;29:52-68. (Pubitemid 33804226)
2. Furrow B. Pain management and provider liability: no more excuses. J Law Med Ethics. 2001;29:28-51. (Pubitemid 33804225)
3. Hoffman D, Tarzian A. The girl who cried pain: a bias against women in the treatment of pain. J Law Med Ethics. 2001;29:13-27. (Pubitemid 33804224)
4. Johnson S. Relieving unnessary, treatable pain for the sake of human diginity. J Law Med Ethics. 2001;29:11-12. (Pubitemid 33804223)
5. Deandrea S, Montanari M, Moja L, Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol. 2008;19:1985-1991.
6. Drayer R, Henderson J, Reidenberg M. Barriers to better pain control in hospitalized patients. J Pain Symptom Manag 1999;17:434-440. (Pubitemid 29289770)
7. Glajcben M. Chronic pain: treatment barriers and strategies for clinical practice. JABFP. 2001;14:211-218.
8. Apfelbaum J, Chen C, Mehta S, Gan T. Postoperative pain experience: results from a National survey suggest postoperative pain continues to be undermanages. Anesth Analg. 2003;97:534-540. (Pubitemid 36899761)
9. Richard J, Reidenberg M. The risk of disciplinary action by State Medical Boards against physicians prescribing opioids. J Pain Symptom Manag. 2005;29:206-212. (Pubitemid 40279057)
10. Upton R, Semple T, Mcintyre P. Pharmacokinetic optimization of opioid treatment in acute pain therapy. Clin Pharmacokinet. 1997;33:225-244. (Pubitemid 27399548)
11. Linares O. Pharmacokinetics-based opioid prescribing: case report. Pain Pract. 2010;20:18-21.
12. Mather L. Opioid pharmacokinetics in relation to their effects. Anaesth Intensive Care. 1987;15:15-22. (Pubitemid 17006793)
13. Shafer S, Varvel J. Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology. 1991;74:55-63.
14. Maitre P. Opioid pharmacokinetics: relationship to response. Curr Opin Anaesthesiol. 1992;5:549-554.
15. Gourlay G, Willis R, Lamberty J. A double-blind comparison of the effcacy of methadone and morphine in postoperative pain control. Anesthesiology. 1986;64:322-327. (Pubitemid 16155860)
16. Ette E, Williams P, Lane J. Population pharmacokinetics III: design, analysis, and application of population pharmacokinetics. Ann Pharmacother. 2004;38:2136-2144. (Pubitemid 40169387)
17. Nehvar R. Estimation of pharmacokinetic parameters based on the patient-adjusted population data. Am J Pharmaceut Educ. 2006;70:1-8.
18. Karch S. Pharmacokinetics and Pharmacodynamics of Abused Drugs. Boca Raton, FL: CRC Press; 2007.
19. Karch S. Drug Abuse Handbook. Boca Raton, FL: CRC Press; 2007.
20. Karch S. Karch's Pathology of Drug Abuse. 4th ed. Boca Raton, FL: CRC Press; 2008.
21. Baselt R. Disposition of Toxic Drugs and Chemicals in Man. 8th ed. Foster City, CA: Biomedical Publications; 2009.
22. Jacob H. Using Published Data: Errors and Remedies. Newbury Park, CA: Sage; 1984.
23. Wastney M, Patterson B, Linares O, Greif P, Boston R. Investigating Biological Systems Using Modeling: Strategies and Software. San Diego, CA: Academic Press; 1999.
24. Efron B. Bootstrap methods: Another look at the jacknife. Ann Stat. 1979;7:1-26.
25. Efron B. Second thoughts on the bootstrap. Stat Sci. 2003;18:135-140. (Pubitemid 37545086)
26. Yafune A, Ishiguro M. Bootstrap approach for constructing con-fdence intervals for population pharmacokinetic parameters. I: a use of bootstrap standard error. Stat Med. 1999;18:581-599. (Pubitemid 29116976)
27. Yafune A, Ishiguro M. Bootstrap approach for constructing con-fdence intervals for population pharmacokinetic parameters. II: a bootstrap modifcation of standard two-stage (STS) method for phase I trial. Stat Med. 1999;18:601-612. (Pubitemid 29116977)
28. Perlin E, Taylor R, Peck C. Clinical pharmacokinetics: a sim-plifed approach, part 1. J Natl Med Assoc. 1985;77:475-482. (Pubitemid 15066343)
29. Perlin E, Varvel J, Peck C. Clinical pharmacokinetics: a simplifed approach, part 2. J Natl Med Assoc. 1986;78: 835-842. (Pubitemid 17189790)
30. Dvorchik B, Vesell E. Signifcance of error associated with use of the one-compartment formula to calculate clearance of thirty-eight drugs. Clin Pharmacol Ther. 1978;23:617-623. (Pubitemid 8364585)
31. Mehvar R. Estimation of pharmacokinetic parameters based on patient-adjusted population data. Am J Pharmaceut Educ. 2006;70:1-8.
32. Ritschel W, Kearns G. Handbook of Basic Pharmacokinetics. 7th ed. Washington, DC: American Pharmacists Association; 2009.
33. Schoenwald R. Pharmacokinetic Principles of Dosing Adjustment. Boca Raton, FL: CRC Press; 2001.
34. Armstrong S, Cozza K. Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: theory and clinical reality. Psychosomatics. 2003;44:515-520. (Pubitemid 37352231)
35. Mehvar R. Pharmacokinetic-based design and modifcation of dosage regimens. Am J Pharmaceut Educ. 1998;62:189-195. (Pubitemid 128655609)
36. Ogden C, Fryar C, Carroll M, Flegal K. Mean Body Weight, Height, and Body Mass Index in the United States 1960-2002. Advanced Data From Vital and Health Statistics; No. 347. Hy-attsville, MD: National Center for Health Statistics; 2004.
37. Sawe J. Morphine kinetics in cancer patients. Clin Pharm Ther. 1981;30:629-635.
38. Arnold D, Grics H, Krewski D. Handbook of in Vivo Toxicity Testing. San Diego, CA: Academic Press; 1990.
39. Hacker M, Bachmann K, Meser W. Pharmacology: Principles and Practice. Burlington, MA: Academic Press; 2009.
40. Jung B, Reidenberg M. Interpretation of opioid levels: comparison of levels during chronic pain therapy to levels from forensic autopsies. Clin Pharmacol Therapeut. 2005;77:324-334. (Pubitemid 40470388)
41. Meier B. OxyContin prescribers face charges in fatal overdoses. The New York Times. January 19, 2002, 2002:14.
42. Flannery J II. Pain in America\And How Our Government Makes it Worse. Ithaca, NY: Ithaca Manor Press; 2006.
43. Spiehler V. Computer-assisted interpretation in forensic toxicology: morphine-involved deaths. J Forensic Sci. 1989;34:1104-1115. (Pubitemid 19236089)
44. Paulozzi L, Ryan G. Opioid analgesics and rates of fatal drug poisonong in the United States. Am J Prev Med. 2006;31:506-511. (Pubitemid 44880582)
45. Unites States v. Hurwitz, 459 F.3d 463 (4th Cir. 2006). 2006.
46. Schulz M, Schimoldt A. Therapeutic and toxic blood concentration of more than 800 drugs and xenobiotics. Pharmazie. 2003;58:447-474. (Pubitemid 36869876)
47. Baumann P, Hiemke C, Ulrich S, Eckerman G, Gaertner I, Gerlach M, et al. The AGNP-TDM Expert Group Consensus Guidelines: therapeutic drug monitoring in psychiatry. Pharma-copsychiatry. 2004;37:243-265. (Pubitemid 39587052)
48. Peck C, Conner D, Murphy M. Bedside Clinical Pharmacoki-netics: Simple Techniques for Individualizing Drug Therapy. Vancouver, WA: Applied Therapeutics; 1991.
49. Efron B, Tibshirani R. Bootstrap measures for standard errors, confdence intervals, and other measures of statistical accuracy. Stat Sci. 1986;1:54-57.
50. Efron B. Better bootstrap confdence intervals (with discussion). J Am Stat Assoc. 1987;82:171-200.
51. Efron B, Tibshirani R. An Introduction to the Bootstrap. New York: Chapman and Hall; 1986.